Country: United States
Language: English
Source: NLM (National Library of Medicine)
CLOPIDOGREL BISULFATE (UNII: 08I79HTP27) (CLOPIDOGREL - UNII:A74586SNO7)
Mylan Institutional Inc.
CLOPIDOGREL BISULFATE
CLOPIDOGREL 75 mg
ORAL
PRESCRIPTION DRUG
- Clopidogrel tablets are indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], including patients who are to be managed medically and those who are to be managed with coronary revascularization. Clopidogrel tablets should be administered in conjunction with aspirin . Clopidogrel . Clopidogrel tablets are indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], including patients who are to be managed medically and those who are to be managed with coronary revascularization. Clopidogrel tablets should be administered in conjunction with aspirin . Clopidogrel . - Clopidogrel tablets are indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI) who are to be managed medically.
Clopidogrel Tablets, USP are available containing 97.875 mg of clopidogrel bisulfate, USP equivalent to 75 mg of clopidogrel base or 391.5 mg of clopidogrel bisulfate, USP equivalent to 300 mg of clopidogrel base. The 75 mg tablets are white, film-coated, round, unscored tablets debossed with M on one side of the tablet and C27 on the other side. They are available as follows: NDC 51079-557-20 – Unit dose blister packages of 100 (10 cards of 10 tablets each). The 300 mg tablets are white, film-coated, oval, unscored tablets debossed with M C28 on one side of the tablet and blank on the other side. They are available as follows: NDC 51079-558-03 – Unit dose blister packages of 30 (5 cards of 6 tablets each). Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] PHARMACIST: Dispense a Medication Guide with each prescription.
Abbreviated New Drug Application
Mylan Institutional Inc. ---------- MEDICATION GUIDE Clopidogrel Tablets, USP (kloe pid′ oh grel) Read this Medication Guide before you start taking clopidogrel tablets and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your doctor about your medical condition or your treatment. What is the most important information I should know about clopidogrel tablets? 1. Clopidogrel tablets may not work as well in people who: 1. have certain genetic factors that affect how the body breaks down clopidogrel tablets. Your doctor may do genetic tests to make sure clopidogrel tablets are right for you. 2. take certain medicines, especially omeprazole (Prilosec ®) or esomeprazole (Nexium ®). Your doctor may change the medicine you take for stomach acid problems while you take clopidogrel tablets. 2. Clopidogrel tablets can cause bleeding which can be serious and can sometimes lead to death. Clopidogrel tablets are a blood thinner medicine that lower the chance of blood clots forming in your body. While you take clopidogrel tablets: 1. you may bruise and bleed more easily 2. you are more likely to have nose bleeds 3. it will take longer for any bleeding to stop Call your doctor right away if you have any of these signs or symptoms of bleeding: • unexpected bleeding or bleeding that lasts a long time • blood in your urine (pink, red or brown urine) • red or black stools (looks like tar) • bruises that happen without a known cause or get larger • cough up blood or blood clots • vomit blood or your vomit looks like coffee grounds Do not stop taking clopidogrel tablets without talking to the doctor who prescribes it for you. People who stop taking clopidogrel tablets too soon have a higher risk of having a heart attack or dying. If you must stop clopidogrel tablets because of bleeding, your risk of a heart attack may be higher. What are clopidogrel tablets? Clopidogrel tablets are a prescription medicine used to treat people who have any of the fo Read the complete document
CLOPIDOGREL BISULFATE- CLOPIDOGREL TABLET, FILM COATED MYLAN INSTITUTIONAL INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE CLOPIDOGREL TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR CLOPIDOGREL TABLETS. CLOPIDOGREL TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 1997 WARNING: DIMINISHED ANTIPLATELET EFFECT IN PATIENTS WITH TWO LOSS-OF-FUNCTION ALLELES OF THE CYP2C19 GENE _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_. EFFECTIVENESS OF CLOPIDOGREL TABLETS DEPENDS ON CONVERSION TO AN ACTIVE METABOLITE BY THE CYTOCHROME P450 (CYP) SYSTEM, PRINCIPALLY CYP2C19. ( 5.1, 12.3) TESTS ARE AVAILABLE TO IDENTIFY PATIENTS WHO ARE CYP2C19 POOR METABOLIZERS. ( 12.5) CONSIDER USE OF ANOTHER PLATELET P2Y12 INHIBITOR IN PATIENTS IDENTIFIED AS CYP2C19 POOR METABOLIZERS. ( 5.1) RECENT MAJOR CHANGES Boxed Warning 9/2016 Indications and Usage ( 1.1, 1.2) 9/2016 Dosage and Administration ( 2.1, 2.2) 9/2016 Warnings and Precautions ( 5.1, 5.2, 5.3) 9/2016 INDICATIONS AND USAGE Clopidogrel tablets are a P2Y platelet inhibitor indicated for: Acute coronary syndrome For patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], clopidogrel tablets have been shown to reduce the rate of myocardial infarction (MI) and stroke. ( 1.1) For patients with ST-elevation myocardial infarction (STEMI), clopidogrel tablets have been shown to reduce the rate of MI and stroke. ( 1.1) Recent MI, recent stroke, or established peripheral arterial disease. Clopidogrel tablets have been shown to reduce the rate of MI and stroke. ( 1.2) DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1) Initiate clopidogrel tablets with a single 300 mg oral loading dose and then continue at 75 mg once daily. Initiating clopidogrel tablets without a loading dose will delay establishment of an antiplatelet effect by several days. Recent MI, recent stroke, or established peripheral arterial disease: 75 mg once dail Read the complete document